Loading…
Loading…
EQUITY / NASDAQ · XNCM
Onconetix Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.7337 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 0.7337 USD · Volume 409,412
251 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 17,120 USD | 106,494 USD | -83.92% |
| Operating profit | -2,730,790 USD | -1,935,418 USD | — |
| Net income | -2,867,303 USD | -2,372,442 USD | — |
| Total liabilities | 2,956,108 USD | — | — |
| Total equity | 13,468,509 USD | 5,909,761 USD | +127.90% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Gross profitIncome statement | 4,303 USD | 2,648 USD | — | — | 632,913 USD | 268,894 USD | 385,229 USD | 70,503 USD |
| Net incomeIncome statement | -2,867,303 USD | -7,082,178 USD | -4,214,875 USD | — | -14,032,342 USD | -8,783,702 USD | -19,702,029 USD | -2,372,442 USD |
| Operating profitIncome statement | -2,730,790 USD | -12,956,591 USD | — | — | -17,856,856 USD | -2,069,242 USD | -16,575,489 USD | -1,935,418 USD |
| RevenueIncome statement | 17,120 USD | 38,577 USD | — | — | 815,371 USD | 303,651 USD | 511,775 USD | 106,494 USD |
| Total assetsBalance sheet | 16,426,341 USD | — | — | 24,926,638 USD | 24,926,638 USD | 19,678,868 USD | — | — |
| Total equityBalance sheet | 13,468,509 USD | — | 11,746,477 USD | 15,764,627 USD | 15,764,627 USD | 3,374,121 USD | — | 5,909,761 USD |
| Total liabilitiesBalance sheet | 2,956,108 USD | — | — | 9,160,287 USD | 9,160,287 USD | 16,303,023 USD | — | — |
| Financing cash flowCash flow statement | — | 4,800,163 USD | — | — | 14,452,686 USD | — | 7,905,978 USD | — |
| Operating cash flowCash flow statement | — | -4,039,548 USD | — | — | -9,678,390 USD | — | -6,587,805 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/13/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.